Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes.

BACKGROUND/AIMS Mdr2 (Abcb4)-/- mice develop hepatic lesions resembling primary sclerosing cholangitis. Our aim was to characterize the evolution of fibrosis in Mdr2-/- mice. METHODS Mdr2-/-mice and their wild-type littermates were sacrificed at 2, 4 and 8 weeks after birth. Hepatic collagen was determined biochemically. Fibrosis related transcript levels were quantified from livers by real-time RT-PCR, and MMP activities determined by substrate assays. Liver histology was assessed by connective tissue staining and immunohistochemistry for alpha-smooth muscle actin (alpha-SMA). RESULTS Mdr2-/- mice demonstrated a time-dependent increase of relative and total hepatic collagen (fivefold at 8 weeks, compared to wildtype controls), and maximal alpha-SMA immunoreactivity at 4 weeks. Compared to wildtype controls profibrogenic mRNA levels for procollagen alpha1(I), TGFbeta1, TGFbeta2, MMP-2 and -13, TIMP-1, PDGFbeta receptor, and PAI-1 were upregulated up to 27-fold. Most transcripts peaked at 4 weeks, but procollagen alpha1(I) mRNA increased steadily, TIMP-1 mRNA was constantly elevated (20-fold), MMP-13 mRNA was suppressed and interstitial collagenase and gelatinase activities were downregulated. CONCLUSIONS Mdr2-/- mice spontaneously progress to severe biliary fibrosis. This is due to a characteristic temporal pattern of upregulated profibrogenic and downregulated fibrolytic genes and activities. These mice are an attractive model to test potential antifibrotics for the treatment of (biliary) liver fibrosis.

[1]  O. Musso,et al.  Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes. , 1997, The American journal of pathology.

[2]  R. Kalluri,et al.  Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. , 2003, Gastroenterology.

[3]  A. Nagler,et al.  Halofuginone to prevent and treat thioacetamide‐induced liver fibrosis in rats , 2001, Hepatology.

[4]  D. Schuppan,et al.  Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. , 1997, The American journal of pathology.

[5]  Y. Itoh,et al.  Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface* , 1998, The Journal of Biological Chemistry.

[6]  J. Iredale,et al.  Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. , 2000, Histology and histopathology.

[7]  Gillian Murphy,et al.  The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.

[8]  Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts , 2001 .

[9]  P. Borst,et al.  Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.

[10]  F. Lammert,et al.  Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. , 2002, Gastroenterology.

[11]  Donald E. Ingber,et al.  Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. , 2000, Journal of cell science.

[12]  S. Friedman,et al.  Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. , 1989, The Journal of biological chemistry.

[13]  E. Jacquemin.  Role of Multidrug Resistance 3 Deficiency in Pediatric and Adult Liver Disease: One Gene for Three Diseases , 2001, Seminars in liver disease.

[14]  A Geerts,et al.  History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.

[15]  H. Tilg,et al.  Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2004, Gastroenterology.

[16]  D. Schuppan,et al.  Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells. , 2003, The American journal of pathology.

[17]  R. Timpl,et al.  Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair , 1999, Histochemistry and Cell Biology.

[18]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[19]  S. Milani,et al.  Transforming growth factor‐β1 regulates platelet‐derived growth factor receptor β subunit in human liver fat‐storing cells , 1995 .

[20]  H. Yoshiji,et al.  Tissue inhibitor of metalloproteinases‐1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse , 2002, Hepatology.

[21]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.

[22]  S. Dooley,et al.  Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. , 2001, FEBS letters.

[23]  D. Schuppan,et al.  Hepatic fibrosis: From bench to bedside , 2002, Journal of gastroenterology and hepatology.

[24]  H. Stein,et al.  Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. , 1991, The American journal of pathology.

[25]  D. Schuppan,et al.  Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen α1(I) and TIMP-1 , 2001 .

[26]  S. Friedman,et al.  Activation of hepatic stellate cells--a key issue in liver fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.

[27]  M. Arthur,et al.  Extracellular Matrix Degradation and the Role of Hepatic Stellate Cells , 2001, Seminars in liver disease.

[28]  Y. Ryoo,et al.  Interferon-γ upregulates the stromelysin-1 gene expression by human skin fibroblasts in culture , 1998, Experimental & Molecular Medicine.

[29]  V. Paradis,et al.  Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.

[30]  S. Dooley,et al.  Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts , 2000, Hepatology.

[31]  D. Schuppan,et al.  Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. , 2001, The American journal of pathology.

[32]  T. Roskams,et al.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. , 2001, Journal of hepatology.

[33]  John P. Iredale,et al.  Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.

[34]  D. Brenner,et al.  A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations , 2004, Hepatology.

[35]  D. Schuppan,et al.  Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.

[36]  D. Schuppan,et al.  An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. , 2000, Gastroenterology.

[37]  S. Friedman,et al.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.

[38]  E. Schiff,et al.  Drug therapy for hepatitis B. , 2001, Advances in internal medicine.

[39]  S. Thorgeirsson,et al.  Tissue inhibitor of metalloproteinases‐1 promotes liver fibrosis development in a transgenic mouse model , 2000, Hepatology.